Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities

ClinicalTrials.gov ID: NCT00724555

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00724555. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to increase treatment of acute stroke with tissue plasminogen activator (tPA) across the District of Columbia. This study, however, will not evaluate tPA as an intervention.

Study identification

NCT ID: NCT00724555
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Georgetown University; Other
Enrollment: 2,005 participants

Conditions and interventions

Conditions

Stroke

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 2008 (Type not available)
Primary completion: Jan 2013 (Actual)
Completion: Jan 2013 (Actual)
Last update posted: Jan 31, 2014

2008 – 2013

United States locations

U.S. sites: 8
U.S. states: 2
U.S. cities: 2

Facility	City	State	ZIP	Site status
Georgetown University, ASPIRE Coordinating Center	Washington D.C.	District of Columbia	20007	—
Washington Hospital Center	Washington D.C.	District of Columbia	20010	—
Sibley Memorial Hospital	Washington D.C.	District of Columbia	20016	—
Providence Hospital	Washington D.C.	District of Columbia	20017	—
United Medical Center (formerly known as Greater Southeast Community Hospital)	Washington D.C.	District of Columbia	20032	—
George Washington University Hospital	Washington D.C.	District of Columbia	20037	—
Howard University Hospital	Washington D.C.	District of Columbia	20060	—
Columbia University Medical Center	New York	New York	10032	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00724555, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 31, 2014 · Synced Nov 12, 2026